# Qiandao Fund

> Qiandao Fund is a VC fund in Beijing backing Health Care, Biotechnology and Medical. See 22 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 22
- Last investment: May 2024
- Lead investor: 27%
- Last updated: Aug 2026

Qiandao Fund is a VC fund in Beijing focused on Health Care and Biotechnology. Qiandao Fund provides equity investment, investment management, and financial services.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 9 | 41% |
| Biotechnology | 8 | 36% |
| Medical | 6 | 27% |
| Manufacturing | 6 | 27% |
| Product Research | 3 | 14% |

26 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 8 | 36% |
| Series A | 5 | 23% |
| Series C | 4 | 18% |
| Seed | 2 | 9% |
| Angel | 1 | 5% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 19 | 86% |
| United States | 2 | 9% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| iBatteryCloud | iBatteryCloud is a manufacturer and solution provider of digital energy storage equipment for the energy internet, focusing on safety and economy in electrochemical energy storage systems. Focusing on a digital energy exchange system that manages battery differences and improves functional indicators like battery life, energy efficiency, balance,reliability, and safety. |  | Series A | May 22, 2024 |  |
| Zhihe Biotechnology | Zhihe Bio is a synthetic biology manufacturer of oleochemicals. | $1.4M | Seed | May 20, 2024 |  |
| Innovo Therapeutics | Innovo Therapeutics is a anti-cancer drug developer committed to research and creation of medications that target protein breakdown. | $14.1M | Seed | Dec 01, 2023 |  |
| Yuntu Semiconductor | Yuntu Semiconductor is a fabless semiconductor and integrated circuit developer in the field of automotive-grade chips. |  | Series B | Nov 01, 2023 |  |
| Ruizhu Technology | Ruizhu Technology is focused on 3D ranging technology in the field of lidar. It is a Sino-foreign joint venture founded by foreign A-class experts and jointly invested by leading listed companies in the industry, government-industry funds, and venture capital. The company's workplace is in Zhongguancun, Haidian District. The founding team hasworked closely with two Nobel Prizes. | $13.7M | Series A | Oct 19, 2023 |  |
| Axiata | Axiata Bio is a R&D and manufacturer of biomedical consumables. | $13.7M | Series A | Sep 19, 2023 |  |
| Yangqi Intelligent | Yangqi Intelligent is a provider of intelligent solutions for medical equipment. |  | Angel | Aug 24, 2023 |  |
| Gene Cradle | Gene Cradle is a genetic company that develops gene therapy drugs to treat rare genetic diseases as well as chronic diseases. | $14M | Series B | Jun 16, 2023 |  |
| Hygea Medical Technology | Hygea Medical Technology is a oncology-focused biopharma company. Hygea’s solutions cater to cancer therapies targeting diseases in the lung, liver, breast, and kidney. Hygea will continue to develop its micro-invasive and Cryo-HITTM technology. | $14.6M | Series D | Feb 15, 2023 |  |
| Hygea Medical Technology | Hygea Medical Technology is a oncology-focused biopharma company. Hygea’s solutions cater to cancer therapies targeting diseases in the lung, liver, breast, and kidney. Hygea will continue to develop its micro-invasive and Cryo-HITTM technology. | $14.6M | Series D | Feb 15, 2023 |  |

10 of 22 investments shown.

## Co-investors
- [Huajin Capital](https://shizune.co/investors/profile/huajin-capital) — VC Fund, 5 deals together
- [Gaorong Capital](https://shizune.co/investors/profile/banyan-capital) — VC Fund, 2 deals together
- [China Merchants Securities](https://shizune.co/investors/profile/china-merchants-securities) — VC Fund, 2 deals together
- [CICC Qide](https://shizune.co/investors/profile/cicc-qide) — VC Fund, 2 deals together
- [DT Capital Partners](https://shizune.co/investors/profile/dt-capital-partners) — VC Fund, 2 deals together
- [GF Venture Capital](https://shizune.co/investors/profile/gf-venture-capital) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Qiandao Fund invest in?

Qiandao Fund invests primarily in Health Care, Biotechnology and Medical startups, most often at Series B and Series A stage. Most of the 22 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Qiandao Fund last invest?

The most recent investment recorded for Qiandao Fund closed in May 2024. Shizune tracks 22 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co